Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identification of hub genes involved in early-onset schizophrenia: from genetic susceptibility to predicted regulated gene expression.

Molecular psychiatry·2026

Same author

Brief Addiction Monitor-Taiwan version as a simple tool for the measurement-based care of people who use drugs in the era of harm reduction: predictive validity in prospective follow-ups of patients nationwide.

Substance abuse treatment, prevention, and policy·2026

Same author

Association of early labor market exit with mental disorders: a population-based cohort study in Taiwan.

Journal of mental health (Abingdon, England)·2026

Same author

APOE ε4 and Accelerated Cognitive Decline Among Cognitively Healthy Middle-Aged and Older Adults.

JAMA network open·2026

Same author

Dysregulated miRNAs and downstream gene expression associated with poor treatment response in first-episode psychosis.

Brain, behavior, & immunity - health·2026

Same author

Gender differences in the relationship between alcohol use patterns and health-related quality of life in a population experiencing a recent surge in harmful alcohol use among females: the 2018 National survey in Taiwan.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2025

Search research articles

Related Experiment Videos

Statistical validation of endophenotypes using a surrogate endpoint analytic analogue.

Guan-Hua Huang¹, Chin-Chiang Hsieh, Chen-Hsin Chen

¹Institute of Statistics, National Chiao Tung University, Hsinchu, Taiwan. ghuang@stat.nctu.edu.tw

Genetic Epidemiology

|February 6, 2009

Summary

This summary is machine-generated.

This study introduces a statistical method to validate endophenotypes, traits linked to disease pathways. The approach uses heritability to confirm if an endophenotype accurately reflects genetic influences on complex diseases.

Related Experiment Videos

Area of Science:

Genetics
Biostatistics
Psychiatry

Background:

Endophenotypes are crucial for understanding complex diseases' genetic basis.
Validating these intermediate phenotypes is essential for genetic research.

Purpose of the Study:

To develop a formal statistical methodology for validating endophenotypes.
To establish criteria for endophenotype validation based on heritability.

Main Methods:

A conditioning strategy, similar to surrogate endpoint validation, was adapted.
An index measuring the proportion of heritability explained was defined.
Statistical inferences for this index were developed.

Main Results:

The proposed method provides a formal framework for endophenotype validation.
Computer simulations demonstrated the method's usefulness.
The Continuous Performance Test was assessed as a potential endophenotype for schizophrenia spectrum disorders.

Conclusions:

The developed statistical methodology offers a rigorous approach to endophenotype validation.
This method can enhance the genetic study of complex diseases by ensuring reliable endophenotype selection.